Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G W Dorn

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|February 18, 1993
Cardiac structure and function in HIV-infected childrenW Lewis, G W Dorn
The American Journal of Physiology|February 1, 1991
Human platelet aggregation and shape change are coupled to separate thromboxane A2-prostaglandin H2 receptorsG W Dorn, A DeJesus
Rational Drug Therapy|July 1, 1985
Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular diseaseG W Dorn, P V Halushka
The American Journal of Physiology|April 1, 1992
Growth factors downregulate vascular smooth muscle thromboxane receptors independent of cell growthG W Dorn, M W Becker
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cellsG W Dorn, M G Davis
The American Journal of Physiology|October 1, 1992
Differential megakaryocytic desensitization to platelet agonistsG W Dorn, M G Davis
Journal of the South Carolina Medical Association (1975)|December 1, 1984
Rapid development of myeloma in a patient with Hodgkin's diseaseG W Dorn, J G Baldwin
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Thromboxane A2 stimulated signal transduction in vascular smooth muscleG W Dorn, M W Becker
Oncogene|July 31, 2009
Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3LG W Dorn, L A Kirshenbaum
Annual Review of Physiology|February 22, 2001
Cytoplasmic signaling pathways that regulate cardiac hypertrophyJ D Molkentin, G W Dorn
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|February 18, 1993
Cardiac structure and function in HIV-infected childrenW Lewis, G W Dorn
The American Journal of Physiology|February 1, 1991
Human platelet aggregation and shape change are coupled to separate thromboxane A2-prostaglandin H2 receptorsG W Dorn, A DeJesus
Rational Drug Therapy|July 1, 1985
Thromboxane synthetase inhibitors, thromboxane receptor antagonists, and aspirin in cardiovascular diseaseG W Dorn, P V Halushka
The American Journal of Physiology|April 1, 1992
Growth factors downregulate vascular smooth muscle thromboxane receptors independent of cell growthG W Dorn, M W Becker
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1992
Thrombin, but not thromboxane, stimulates megakaryocytic differentiation in human megakaryoblastic leukemia cellsG W Dorn, M G Davis
The American Journal of Physiology|October 1, 1992
Differential megakaryocytic desensitization to platelet agonistsG W Dorn, M G Davis
Journal of the South Carolina Medical Association (1975)|December 1, 1984
Rapid development of myeloma in a patient with Hodgkin's diseaseG W Dorn, J G Baldwin
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1993
Thromboxane A2 stimulated signal transduction in vascular smooth muscleG W Dorn, M W Becker
Oncogene|July 31, 2009
Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3LG W Dorn, L A Kirshenbaum
Annual Review of Physiology|February 22, 2001
Cytoplasmic signaling pathways that regulate cardiac hypertrophyJ D Molkentin, G W Dorn
Pageof 9